{"id":"559417-9102","orgnr":"559417-9102","name":"Linnane Projects AB","name_registered_on":"2023-01-16","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2023-01-16","business_description":"Aktiebolaget ska bedriva och främja forskning, utveckling och försäljning av produkter inom det medicinska området och andra hälsorelaterade områden genom egen verksamhet, som konsult eller genom intressebolag ävensom idka därmed jämförlig verksamhet samt äga och förvalta aktier och andra värdepapper.","postal_address":{"street":"Slottsgatan 32","care_of":"c/o Svanborg","postal_code":"21133","city":"MALMÖ","country":"SE","municipality":{"code":"1280","name":"Malmö"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1280","name":"Malmö"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"never_active","employee_class":{"code":"1","name":"0 anställda"},"f_tax":"never_registered","vat":"never_registered","employer":"never_registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2024-07-01","to":"2025-06-30","framework":"K3","signed_on":"2025-12-08","documents":{"annual_report":"/v1/documents/605d7cdb-dd24-4c97-9cd0-ab246f7719dd.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/51_4.zip"}},{"from":"2023-07-01","to":"2024-06-30","framework":"K3","signed_on":"2024-12-19","documents":{"annual_report":"/v1/documents/7fd25aaf-339e-4067-bec4-b33af319794e.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/03_3.zip"}},{"from":"2023-01-16","to":"2023-06-30","framework":"K3","signed_on":"2023-12-20","documents":{"annual_report":"/v1/documents/539f7561-dffd-41b6-93a7-22ee78735080.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/12_5.zip"}}],"latest_financials":{"from":"2024-07-01","to":"2025-06-30","scope":"company","currency":"SEK","net_sales":0,"operating_profit":0,"profit_after_financial_items":0,"net_profit":0,"total_assets":25000,"current_assets":25000,"equity":25000,"share_capital":25000,"unrestricted_equity":0,"cash":25000,"equity_ratio":1,"source":{"annual_report":"2025-06-30","document":"/v1/documents/605d7cdb-dd24-4c97-9cd0-ab246f7719dd.xhtml"},"anchors":{"cash":{"text":"25 000","prefix":"Summa kassa och bank","suffix":"25 000"},"current_assets":{"text":"25 000","prefix":"omsättningstillgångar"},"equity":{"text":"25 000","prefix":"Summa eget kapital"},"equity_ratio":{"text":"100","prefix":"Soliditet %"},"net_profit":{"text":"0","prefix":"resultat","suffix":"0"},"net_sales":{"text":"0","prefix":"Nettoomsättning"},"operating_profit":{"text":"0","prefix":"Rörelseresultat"},"share_capital":{"text":"25 000","prefix":"Utgående balans"},"total_assets":{"text":"25 000","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"0","prefix":"disponera"}}},"officers":{"annual_report":"2025-06-30","signed_on":"2025-12-08","signatories":[{"name":"C*****","role":"Styrelseledamot"}]},"group":{"group_parent":{"id":"556568-8958","name":"Hamlet BioPharma AB","source":{"by":"subsidiary","annual_report":"2025-06-30"},"no_digital_report":true}}}